European Biotech Acquisition Corp. Warrant
EBACW
EBACW was delisted on the 2nd of March, 2023.
30 hedge funds and large institutions have $1.61M invested in European Biotech Acquisition Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
15% more funds holding
Funds holding: 26 → 30 (+4)
8% less capital invested
Capital invested by funds: $1.75M → $1.61M (-$133K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$98.9K |
| 2 |
AMH
Apollo Management Holdings
New York
|
+$21.3K |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$10.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$256 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Athanor Capital
New York
|
-$380K |
| 2 |
LA
Linden Advisors
New York
|
-$16K |
| 3 |
EAM
Exos Asset Management
New York
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OAC
26
OMERS Administration Corp
Toronto,
Ontario, Canada
| $7K | – | – | – |
|
|
VI
27
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $7K | – | – | – |
|
|
SAMU
28
SONA Asset Management (US)
New York
| $4K | +$4.68K | +7,320 | New |
|
|
AA
29
Ancora Advisors
Cleveland,
Ohio
| $1K | – | – | – |
|
|
AC
30
Athanor Capital
New York
| – | -$380K | -39,251 | Closed |
|
|
EAM
31
Exos Asset Management
New York
| – | -$9K | -15,100 | Closed |
|
|
32
UBS Group
Zurich,
Switzerland
| – | +$256 | +400 | New |
|
EBACW Hedge Fund Activity: Q4 2021 in Review
30 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q4 2021, worth a combined $1.61M — down 7.6% from $1.75M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new EBACW positions and 3 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $98.9K. The largest seller was Athanor Capital, exiting entirely with an estimated $380K sold.
- 30 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q4 2021, up from 26 in Q3 2021.
- Funds reported $1.61M of European Biotech Acquisition Corp. Warrant stock for Q4 2021, down 7.6% quarter-over-quarter.
- 7 funds opened new European Biotech Acquisition Corp. Warrant positions in Q4 2021 and 3 closed out, a net change of +4 holders.
- The largest European Biotech Acquisition Corp. Warrant buyer in Q4 2021 was Periscope Capital, an estimated $98.9K added.
- The largest European Biotech Acquisition Corp. Warrant seller in Q4 2021 was Athanor Capital, an estimated $380K sold.
Based on aggregated 13F filings for Q4 2021.